Search

everythinglearnresearchcommunity

for

Search:↓

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Two specific SNPs in the TRPS1 gene cause excessive hair growth by altering the protein's structure.

The KRTAP21-1 gene affects wool yield and can help improve wool production.

Overexpression of R-spondin 3 leads to sparse hair and impaired hair regeneration.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

The type 3 IP3 receptor is important for controlling hair loss and growth.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Mutations in the P2RY5 gene cause autosomal recessive woolly hair.

JAK inhibitors might help treat alopecia areata.

Certain gene mutations in Japanese people are linked to different types of hair loss, with some causing mild hair thinning and others leading to complete baldness.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

The research suggests that a specific skin gene can be controlled by signals within and between cells and is wrongly activated in certain skin diseases.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Immortalized rat dermal papilla cells can still induce hair growth.

A mutation in the VDR gene affects hair cycling without needing ligand binding.

Certain mutations in the hairless protein disrupt its ability to regulate the hair cycle.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

The early genes of a specific virus can cause abnormal skin cell growth and hair follicle changes.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.